TrialAntimicrobial agents and chemotherapy2016

A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers.

Kiran Dole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.